Knowledge Sourcing Intelligence announces the publication of a new report on “Molecular Imaging Market - Forecasts from 2020 to 2025” to their offering.

With continuous technological advancements to which the medical diagnostics segment has been subjected, has led to a profusion of developments. One such development is that of molecular imaging which in comparison is a new technology. It is has gained wide recognition due to its capability of providing valuable insights of especially because the onset of diseases leads to various changes in a body’s biochemical activities. Moreover, with the gradual progression of the diseases, various aspects of the body are subjected to these changes which are minute. To this end the facility of molecular imaging aids in satisfactory diagnostics by capturing these changes and assisting the physicians, specialists, and healthcare professionals to arrive at the appropriate decisions to prescribe a suitable treatable. Further, in comparison with other technologies like compound tomology (CT) scan and magnetic resonance imaging (MRI), molecular imagingis the most superior technology thus far. The application areas that are poised to drive the growth of the molecular imaging market concomitantly hold the largest market share cardiovascular ailments, oncology, and neurology. The other applications that are expected to influence the market are Alzheimer’s, aneurysms,bone disorders, brain diseases,myocardial perfusion, organ malfunctioning, Parkinson’s disease, and tumors. There are different types of devices such as Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, among others that make up the device segment of the market.
The market players are also proactively engaging in various strategic moves to consolidates their position in this market Viz. in June 2019, a global leader in diagnostic imaging called Bracco Imaging S.p.A. had reportedly announced that it had signed a definitive agreement to acquire a molecular imaging company based in Oxford, the UK named Blue Earth Diagnostics, to enhance Bracco’sportfolio in precision medicine and personalized diagnostics, simultaneously leading to an expansion ofthe variety of nuclear oncology imaging solutions in the Urology segment and other specialties. Earlier in January 2019, China's Shanghai United Imaging Healthcare Co. Ltd. (UIH)had reportedly announced that it had received clearance from U.S. Food & Drug Administration (FDA) for the uExplorer which is reportedly the world’s first combined positron emission tomography (PET) and X-ray computed tomography (CT) scanner with the capability to image an entire body in 3d format.
Purchase the complete report or request for a sample:
https://www.knowledge-sourcing.com/report/molecular-imaging-market
The recent study on the Molecular Imaging Market covers an in-depth analysis of the market on the basis of device type, application, end-user, and geography. The report also covers the country-level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraint during the forecast period 2020-2025. According to the report titled “Molecular Imaging Market – Forecasts from 2020 to 2025”, the market is estimated to grow at a steady rate during the forecast period. The report has segmented the Molecular Imaging Market by Device Type (Positron Emission Tomography (PET) Scanner, Single Photon Emission Computed Tomography (SPECT) Scanner, Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, Others), By Application (Cardiovascular, Neurology, Respiratory, Oncology, Other) and by Geographies such as North Americas (USA, Canada, Mexico, and others), South America (Brazil, Argentina, and others), Europe (Germany, France, United Kingdom, Spain, Others), Middle East and Africa (Saudi Arabia, Israel, Others), and Asia Pacific (China, Japan, South Korea, India, Others).
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the global Molecular Imaging Market.
Major players covered as part of the report areCanon Medical System Corporation, Esaote SpA, GE Healthcare, Hitachi High-Technologies Corporation, Hologic, Inc., Koninklijke Philips N.V., Shimadzu Corporation,and Siemens Healthcare GmbHamong others.
Segmentation
This report segmented the Molecular Imaging Market on the basis following terms
By Device Type
• Positron Emission Tomography (PET) Scanner
• Single Photon Emission Computed Tomography (SPECT) Scanner
• Gamma Camera
• Nuclear Magnetic Resonance (NMR) Spectrometer
• Others
By Application
• Cardiovascular
• Neurology
• Respiratory
• Oncology
• Other
By Geography
North America
• USA
• Canada
• Mexico
• Others
South America
• Brazil
• Argentina
• Others
Europe
• Germany
• France
• United Kingdom
• Spain
• Others
The Middle East and Africa
• Saudi Arabia
• Israel
• Others
Asia Pacific
• China
• Japan
• South Korea
• India
• Others

Unique reasons to buyMolecular Imaging Market report-
1. In-depth analysis with sufficient data points and references included.
2. Best possible insights in addition to a detailed analysis of drivers and restraints.
3. Comparison between the market players and in-depth analysis of their strategies through competitive benchmarking.
4. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments.


Scope of Research of Molecular Imaging Market -
1. The forecast period is from 2020 to 2025with 2019 as the base year.
2. Leading industry trends and regulations, key business opportunities, drivers and restraints at the global and regional level
3. Strategies of the key players in analyzing the competitive benchmarking are provided in the report
4. Corporate profiles of leading players along with their financial profiles across regions and industry verticals can be provided on customization requests.

Knowledge Sourcing Intelligence
539 W. Commerce St #2401
Dallas, TX 75208
Email: [email protected]
Phone: +1-850-250-1698